Drug Shortage Report for PROBUPHINE
| Report ID | 108477 |
| Drug Identification Number | 02474921 |
| Brand name | PROBUPHINE |
| Common or Proper name | Probuphine |
| Company Name | KNIGHT THERAPEUTICS INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | BUPRENORPHINE HYDROCHLORIDE |
| Strength(s) | 80MG |
| Dosage form(s) | IMPLANT |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 1 |
| ATC code | N07BC |
| ATC description | |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2020-03-11 |
| Actual start date | 2020-03-11 |
| Estimated end date | 2020-04-20 |
| Actual end date | 2020-04-20 |
| Shortage status | Resolved |
| Updated date | 2020-04-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3400 DE MAISONNEUVE BLVD W MONTREAL, QUEBEC CANADA H3Z 3B8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2020-04-21 | English | Compare |
| v8 | 2020-04-20 | French | Compare |
| v7 | 2020-04-20 | English | Compare |
| v6 | 2020-04-14 | French | Compare |
| v5 | 2020-04-14 | English | Compare |
| v4 | 2020-04-14 | English | Compare |
| v3 | 2020-03-12 | English | Compare |
| v2 | 2020-03-11 | French | Compare |
| v1 | 2020-03-11 | English | Compare |
Showing 1 to 9 of 9